Morpholine → 1-[3-Chloro-5-[3-(4-fluoro-phenyl)-butoxy]-4-methoxy-2-methyl-6-(2-morpholin-4-yl-ethoxy)-phenyl]-ethanone
Reaktionsgleichung
Br[CH2:2][CH2:3][O:4][C:5]1[C:10]([O:11][CH2:12][CH2:13][CH:14]([C:16]2[CH:21]=[CH:20][C:19]([F:22])=[CH:18][CH:17]=2)[CH3:15])=[C:9]([O:23][CH3:24])[C:8]([Cl:25])=[C:7]([CH3:26])[C:6]=1[C:27](=[O:29])[CH3:28].[NH:30]1[CH2:35][CH2:34][O:33][CH2:32][CH2:31]1>>[Cl:25][C:8]1[C:7]([CH3:26])=[C:6]([C:27](=[O:29])[CH3:28])[C:5]([O:4][CH2:3][CH2:2][N:30]2[CH2:35][CH2:34][O:33][CH2:32][CH2:31]2)=[C:10]([O:11][CH2:12][CH2:13][CH:14]([C:16]2[CH:21]=[CH:20][C:19]([F:22])=[CH:18][CH:17]=2)[CH3:15])[C:9]=1[O:23][CH3:24]Komponenten
3
Versuchsvorschrift
Example 8a (100 mg, 0.21 mmol) was reacted with morpholine (6.0 eq.) as described under General Procedure G. The title compound was afforded as an oil (72 mg, 71%). 1H NMR (300 MHz, CDCl3) δ 7.18-7.13 (m, 2H), 6.99-6.89 (m, 2H), 4.05 (t, J=5.7 Hz, 2H), 3.94 (t, J=6.7 Hz, 2H), 3.82 (s, 3H), 3.70-3.67 (m, 4H), 3.02-2.95 (m, 1H), 2.59 (t, J=5.7 Hz, 2H), 2.49 (s, 3H), 2.47-2.44 (m, 4H), 2.17 (s, 3H), 2.03-1.96 (m, 2H), 1.28 (d, J=7.0 Hz, 3H). MS (ES+) m/z 493.9 (M+H+).